Healthcare: Medical Products - Press Releases

"A&G Pharmaceutical, Inc. - Product Pipeline Analysis, 2014 Update" Published

LogoA&G Pharmaceutical, Inc. (A&G) is a pharmaceutical company. The company discovers, develops and markets pharmaceutical products which improve screening, monitoring, and targeted treatment of cancer. Its product pipeline includes OncoStain 88, Onco88 and GP88. A&G offers molecular diagnostic tests and drugs for cancer, and test kits to improve detection, diagnosis, and treatment of breast cancer. A&G provides antibodies for ovarian, pancreatic, prostate, and lung cancer. The company markets products under the brand names such as Herceptin, HercepTest, and others. It serves pharmaceutical and biotechnology companies, and laboratories. A&G is headquartered in Columbia, Maryland, the US.

New Market Research Report: Asia-Pacific Esophagoscopes & Gastroscopes Market Outlook to 2020

LogoAsia-Pacific Esophagoscopes & Gastroscopes Market Outlook to 2020

New Market Research Report: India Biopsy Devices Market Outlook to 2020

LogoIndia Biopsy Devices Market Outlook to 2020

BRIC Ureteroscopes Market Outlook to 2020 - New Market Research Report

LogoBRIC Ureteroscopes Market Outlook to 2020

"PrognosDx Health, Inc. - Product Pipeline Analysis, 2014 Update" Published

LogoPrognosDx Health, Inc. (PrognosDx) is a biotechnology company. The company develops products for the treatment of cancer and other complex diseases. Its products include prognoscore and rxscore. PrognosDx's prognoscore is used in the treatment of prostate cancer and bladder cancer. The company's rxscore is a therapeutic test for pancreatic, breast, colorectal, and lung cancers. The company conducts clinical validation studies at medical centers throughout the US. PrognosDx is headquartered in Palo Alto, California, the US.

United Kingdom General Surgery Outlook to 2020 - New Market Report

LogoGlobalData's new report, "United Kingdom General Surgery Outlook to 2020", provides key market data on the United Kingdom General Surgery Procedures. The report provides procedure volumes within market segments - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.

"Asia-Pacific Biopsy Procedures Outlook to 2020" Is Now Available at Fast Market Research

LogoGlobalData's new report, "Asia-Pacific Biopsy Procedures Outlook to 2020", provides key market data on the Asia-Pacific Biopsy Procedures. The report provides procedure volumes within market segments - Prostate Biopsy Procedures, Breast Biopsy Procedures, Lung Biopsy Procedures, Colorectal Biopsy Procedures, Thyroid Biopsy Procedures and Liver Biopsy Procedures.

My IDentity Doctor Is Offering Peanut Allergy Bracelets to Manage Nut and Peanut Allergies in Primary Schools

Bringing efficient strategies, My IDentity Doctor now offers Peanut allergy bracelets to manage nut and peanut allergies in primary schools. It has been seen from the recent researches that children from the age group of 3-8 years are more prone to food allergies. This is the reason they have found a solution to this problem. They are now providing Kid’s medical ID bracelets to ensure complete safety as kids can also come in contact with many other children.

Report Published: "Nuvera Biosciences, Inc. - Product Pipeline Analysis, 2014 Update"

LogoNuvera Biosciences, Inc. (Nuvera) is a diagnostic solution provider. The company develops novel molecular diagnostics and detection techniques for treatment of cancer. It develops clinically validated tests for therapy response. Nuvera has its collaboration with academic and industrial groups in, clinical bioinformatics, cancer genomics and conducts advanced molecular analyses to develop predictive tests for cancer therapies. Its diagnostic development is based on multi-gene profiling in prospective treatment-specific trials developed at MDACC. The company offers products for colon, lung and esophageal cancer, among others. It partners with M.D. Anderson Cancer Center, Veridex, LLC, and Tufts University. Nuvera is headquartered in Saugas, Massachusetts, the US.

"JetGuide Ltd. - Product Pipeline Analysis, 2014 Update" Is Now Available at Fast Market Research

LogoJetGuide Ltd. (JetGuide) is a medical device company. The company develops and markets systems for real-time intraoperative monitoring of bone drilling and dissecting tumor from soft healthy tissue. Its products include spine system, ortho system, and dental system. JetGuide's technology is based on ultrasonic wave transmission and reception of liquid to measure the distance between the bottom of the drilled bore in the bone and the upper layer of sensitive tissue throughout the drilling procedure. The company's ortho systems are used in the surgeries of hip, pelvis, shoulder fractures, complex fractures in lower extremities and small joints. JetGuide is headquartered in Haifa, Israel.

Just Published: "Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis, 2014 Update"

LogoAmorfix Life Sciences Ltd. (Amorfix) is a development stage biopharmaceutical company. It focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company developed two new technologies, namely, Epitope Protection and AMFIA for identifying low levels of misfolded proteins in the biological samples which helped in generating cerebrospinal fluid screening test for Alzheimer's disease. The company's products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. Amorfix is headquartered in Mississauga, Ontario, Canada.

"Russia Biopsy Devices Market Outlook to 2020" Is Now Available at Fast Market Research

LogoGlobalData's new report, "Russia Biopsy Devices Market Outlook to 2020", provides key market data on the Russia Biopsy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biopsy Guns (Disposable and Reusable Biopsy Guns), Biopsy Needles (Core Needles, Fine Aspiration Needles (Disposable and Reusable Fine Aspiration Needles) and Disposable Vacuum-Assisted Needles), Biopsy Forceps (Disposable and Reusable Biopsy Forceps) and Biopsy Punches (Disposable and Reusable Biopsy Punches).

New Market Study, "United States General Surgery Outlook to 2020", Has Been Published

LogoGlobalData's new report, "United States General Surgery Outlook to 2020", provides key market data on the United States General Surgery Procedures. The report provides procedure volumes within market segments - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.

New Market Study, "BRIC Resectoscopes Market Outlook to 2020", Has Been Published

LogoGlobalData's new report, "BRIC Resectoscopes Market Outlook to 2020", provides key market data on the BRIC Resectoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Rigid Resectoscopes and Resectoscopes Electrodes (Monopolar (Disposable and Reusable) Electrodes and Bipolar (Disposable and Reusable) Electrodes).

Verisante Technology, Inc. (VRS) - Product Pipeline Analysis, 2014 Update - New Report Available

LogoVerisante Technology, Inc. (Verisante), formerly T-Ray Science, Inc., is a medical device company. It carries out the development and commercialization of products for the early detection of all forms of skin cancer. The company's key product offerings include Verisante Aura and Verisante Core. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. Verisante is headquartered in Vancouver city, British Columbia, Canada.

Recent Study: Nanospectra Biosciences, Inc. - Product Pipeline Analysis, 2014 Update

LogoNanospectra Biosciences, Inc. (Nanospectra) is a life science company. The company develops and commercializes particle based therapies for destruction of solid tumors. It offers AuroLase therapy that destroys cancer tissue without damage to surrounding healthy tissue. The company's research use only products include gold nanoshell and custom production products. Nanospectra develop medical and commercial applications of nanoparticles. It has a license from Rice University to eleven issued US patents related to nanoshells and related commercial uses of these and other nanoparticles. The company conducts pilot study in patients with refractory head and neck cancer. Nanospectra is headquartered in Houston, Texas, the US.

EU5 Endoscopy Fluid Management Systems Market Outlook to 2020 - New Market Report

LogoEU5 Endoscopy Fluid Management Systems Market Outlook to 2020

Recent Study: SHL Medical - Product Pipeline Analysis, 2014 Update

LogoSHL Medical (SHL) is a medical device company. The company designs, develops and manufactures drug delivery devices. Its products include auto injectors, grip syringe holder, adjustable multi-dose injector, dual chamber pen injector and eye drop delivery aid. The company provides services, such as design and innovation, manufacturing, regulatory affairs, quality system, intellectual property, global logistics, project management and final assembly services. SHL markets its products under the brand names, Amber, Molly, DAI, DAI-RNS, DAI-R, SDI MIX+NIT, VSDI, PSDI, Naisa, PPI, Madie, GRIP, DCP and Xal-Ease. The company serves pharmaceutical and biotechnology companies. It has operations in the US, Sweden and Taiwan. The company operates as a division of SHL Group. SHL Medical is headquartered in Deerfield Beach, New Jersey, the US.

"India Bronchoscopes Market Outlook to 2020" Now Available at Fast Market Research

LogoIndia Bronchoscopes Market Outlook to 2020

Samyang Genex Corporation (003940) - Product Pipeline Analysis, 2014 Update - New Study Released

LogoSamyang Genex Corporation (Samyang Genex) is a food ingredient manufacturing company. It carries out the manufacture and commercialization of ingredients for pharmaceutical, paper, food, textile and cosmetics industries. The company specializes in the production of various kinds of starches, meals and sweeteners based on corn. Samyang Genex's starch and sweetener product portfolio includes native starches, modified starches, corn sweeteners, polyols and others. The company also carries out the production of corn-based meals, feeds and by-products. The company's prime brands include Genexol, Suntex and Sunstar, among others. It exports products to more than 20 countries including the US, Japan, China, Australia and countries in Southwest Asia, Eastern Europe and Southeast Asia. Samyang Genex is headquartered in Seoul, South Korea.

Market Report, "China Resectoscopes Market Outlook to 2020", Published

LogoChina Resectoscopes Market Outlook to 2020

MP Biomedicals Introduces the FastPrep-24 5G the Most Advanced Sample Preparation Instrument Available

Mechanical sample lysis is rapidly becoming the preferred sample preparation method in life science labs for the isolation of DNA, RNA, proteins, metabolites and other small molecules because the elimination of chemicals, enzymes, and detergents minimizes the introduction of potential inhibitors to downstream processes. The FastPrep-24 5G™ is the newest innovation in benchtop reciprocating homogenizers offering the ultimate in speed and performance for the optimal lysis of biological samples. The FastPrep-24 5G is a software controlled, standalone instrument, designed with a first-of-its-kind user-friendly touch screen interface as well as many unique and innovative features.

My IDentity Doctor, a Prominent Name for Medical ID Jewelry, Now Discusses the National Childhood Obesity Awareness Month

Studies show that one in every three children in the USA exhibits signs of being obese or overweight and this rate has been consistently increasing with time. In an attempt to raise awareness about this issue, September has been chosen as National Childhood Obesity Awareness Month and My IDentity Doctor, a prominent name for Medical ID Jewelry, now discusses the issues of childhood obesity. This month is observed all across the country in a big way to highlight the health issues that arise on account of overweight and also to spread knowledge about the measures that help curb obesity in kids.

Market Report, "KineMed, Inc. - Product Pipeline Analysis, 2014 Update", Published

LogoKineMed, Inc. (KineMed) is a biotechnology company. The company discovers and develops biomarkers. Its services include pre-clinical, clinical activity and patient stratification data. The company's patented isotopic tracer technology helps clients in tracking chemical pathways within living systems. KineMed concentrates in the therapeutic areas of muscle metabolism, proteome metabolism, inflammation, immunity, neurobiology, plasma lipids and lipoproteins, pancreatic islet cell proliferation and lipid synthesis. Its product pipeline includes KM-011 - apo-A1 and noscapine and noscapine analogues. KineMed is headquartered in Emeryville, California, the US.

New Market Research Report: North America Resectoscopes Market Outlook to 2020

LogoNorth America Resectoscopes Market Outlook to 2020